BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pellicano R, Ianiro G, Fagoonee S, Settanni CR, Gasbarrini A. Review: Extragastric diseases and Helicobacter pylori. Helicobacter 2020;25 Suppl 1:e12741. [PMID: 32918343 DOI: 10.1111/hel.12741] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Kountouras J, Papaefthymiou A, Polyzos SA, Deretzi G, Vardaka E, Soteriades ES, Tzitiridou-Chatzopoulou M, Gkolfakis P, Karafyllidou K, Doulberis M. Impact of Helicobacter pylori-Related Metabolic Syndrome Parameters on Arterial Hypertension. Microorganisms 2021;9:2351. [PMID: 34835476 DOI: 10.3390/microorganisms9112351] [Reference Citation Analysis]
2 Li R, Zhang P, Hu Z, Yi Y, Chen L, Zhang H. Helicobacter pylori reinfection and its risk factors after initial eradication: A protocol for systematic review and meta-analysis. Medicine (Baltimore) 2021;100:e25949. [PMID: 34106668 DOI: 10.1097/MD.0000000000025949] [Reference Citation Analysis]
3 Durazzo M, Adriani A, Fagoonee S, Saracco GM, Pellicano R. Helicobacter pylori and Respiratory Diseases: 2021 Update. Microorganisms 2021;9:2033. [PMID: 34683354 DOI: 10.3390/microorganisms9102033] [Reference Citation Analysis]
4 Attaran B, Salehi N, Ghadiri B, Esmaeili M, Kalateh S, Tashakoripour M, Eshagh Hosseini M, Mohammadi M. The penicillin binding protein 1A of Helicobacter pylori, its amoxicillin binding site and access routes. Gut Pathog 2021;13:43. [PMID: 34183046 DOI: 10.1186/s13099-021-00438-0] [Reference Citation Analysis]
5 Biernat MM, Wróbel T. Bacterial Infection and Non-Hodgkin B-Cell Lymphoma: Interactions between Pathogen, Host and the Tumor Environment. Int J Mol Sci 2021;22:7372. [PMID: 34298992 DOI: 10.3390/ijms22147372] [Reference Citation Analysis]
6 Yue CY, Peng Y, Gao CB, Zhang GS, Zhang F, Dong LL. Relationship between Helicobacter pylori infection and Hashimoto's thyroiditis: A prospective study. Shijie Huaren Xiaohua Zazhi 2021; 29(2): 75-80 [DOI: 10.11569/wcjd.v29.i2.75] [Reference Citation Analysis]
7 Yu J, Zhao Y, Wang X, Xu Y. Evaluation of Anti-Helicobacter pylori IgG Antibodies for the Detection of Helicobacter pylori Infection in Different Populations. Diagnostics 2022;12:1214. [DOI: 10.3390/diagnostics12051214] [Reference Citation Analysis]
8 Mladenova I. Clinical Relevance of Helicobacter pylori Infection. J Clin Med 2021;10:3473. [PMID: 34441769 DOI: 10.3390/jcm10163473] [Reference Citation Analysis]
9 Adriani A. Helicobacter pylori as potential agent in the pathogenesis of dementia. Minerva Med 2021;112:817. [PMID: 35168307 DOI: 10.23736/S0026-4806.21.07772-7] [Reference Citation Analysis]
10 Naoum G, Markantonis SL, Fanerou E, Siagkas G, Petropoulos F, Zafiris E, Kousovista R, Karalis V. On the Association between Gastrointestinal Symptoms and Extragastric Manifestations. Gastroenterol Res Pract 2022;2022:8379579. [PMID: 35761833 DOI: 10.1155/2022/8379579] [Reference Citation Analysis]
11 Krzyżek P, Grande R, Migdał P, Paluch E, Gościniak G. Biofilm Formation as a Complex Result of Virulence and Adaptive Responses of Helicobacter pylori. Pathogens 2020;9:E1062. [PMID: 33353223 DOI: 10.3390/pathogens9121062] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
12 Durazzo M, Ferro A. Cardiovascular prevention: beyond the classical risk factors. Panminerva Med 2022;64:132-3. [PMID: 35330557 DOI: 10.23736/S0031-0808.21.04502-X] [Reference Citation Analysis]
13 Martin-Nuñez GM, Cornejo-Pareja I, Clemente-Postigo M, Tinahones FJ. Gut Microbiota: The Missing Link Between Helicobacter pylori Infection and Metabolic Disorders? Front Endocrinol (Lausanne) 2021;12:639856. [PMID: 34220702 DOI: 10.3389/fendo.2021.639856] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]